Outcome of Board Meeting

October 29, 2026 To To The Corporate Relations Department The Listing Department BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Code: 540222 Code: LAURUSLABS Dear Sir / Madam, Sub: Outcome of the Board Meeting – October 29, 2026 We would like to inform that the Board of Directors of the Company at their meeting held on October 29, 2026, has inter alia transacted and approved the following businesses: (1) Approval of Unaudited Financial Results for the quarter and half-year ended September 30, 2026 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), the Board of Directors approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2026, which are annexed herewith along with the Limited Review Reports issued by Deloitte Haskins & Sells LLP, the Statutory Auditors of the Company. The financial results will be available on the website of the Company at www.lauruslabs.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseinda.com, respectively. (2) Approval for the payment of Interim Dividend for FY 2026-27 The Board of Directors approved the payment of Interim Dividend of Re. 1.00/- (i.e., 50%) per equity share of Rs.2/- each, for the Financial Year 2026-27. Further, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Company has fixed “November 6, 2026” as the “Record Date” for determining the eligibility of the Shareholders. The Dividend amount will be paid on or after November 19, 2026. (3) Approval for the appointment of Mr. Kundan Kumar Jha, as Joint Company Secretary The Board of Directors approved the appointment of Mr. Kundan Kumar Jha (Associate Member of the Institute of Company Secretaries of India holding Membership No. A17612), as Joint Company Secretary, being a Key Managerial Personnel of the Company, with effect from November 1, 2026, in line with the Company’s succession planning process. The Board Meeting commenced at 02.00 p.m. (IST) and concluded at 02.47 p.m. (IST). This is for your information and records. Thanking you. Yours sincerely, For Laurus Labs Limited V V Ravi Kumar Executive Director and CFO DIN: 01424180 Encl: A/a LAURUSLabs Chemistry for Better Living LAURUS LABS LIMITED (CIN: L24239AP2005PLC047518) Regd.Office: Laurus Enclave, Plot Office 01, E. Bonangi Village, Parawada Mandai, Anakapalli District, Andhra Pradesh-531021 Corp.Office: Plot No. 103, Road No.1, Jubilee Hills, Hyderabad 500033, Telangana, India. Tel: +91 040 6659 4333; Fax: +91 040 6659 4320; E-mail: secretarial@lauruslabs.com; Website: www.lauruslabs.com STATEMENT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30,2026 ?. ill Crores Quarter ended Six montbs ended Year ended No. Particulars 30-Sep-26 30-Jun-26 3~Sep-25 30-Sep-26 30-Sep-25 31-Mar-26 (Unaudited) (Unaudited} (Unaudited) (Unaudited} (Unaudited} (Audited) 1 Income (a) Revenue from operations 2,206.37 2,026.31 1,653.47 4,232.68 3,223.04 6,812.90 (b) Other income 13.01 9.18 26.96 22.19 37.39 54.95 Total income 2,219.38 2,035.49 1,680.43 4,254.87 3,.260.43 6,867.85 2 Expenses (a) Cost of materials consumed 900.69 785.77 676.75 1,686.46 1,276.16 2,794.34 (b) Purchase of traded goods 45.01 35.12 30.70 80.13 69.20 17256 (c) Changes in inventories of finished goods, work-in·progress and stock-in-trade (129.61) (64.88) (44.01) (194.49) (44.57) (271.44) (d) Employee benefits expense 265.71 258.70 215.56 524.41 430.36 895.45 (e) Other expenses 374.27 373.33 371.21 747.60 706.50 1,444.28 (f) Depreciation and amortisation expense 127.39 123.87 120.49 251.26 237.33 480.05 (g) Finance costs 44.10 42.22 40.00 86.32 91.50 170.73 Total expenses 1,627.56 1,554.13 1,410.70 3,181.69 2,766.48 5,685.97 3 Profit before tax (1-2) 591.82 481.36 269.73 1,073.18 493.95 1,181.88 4 Tax expense (a) Current tax 16294 134.88 87.91 297.82 147.93 297.52 (b) Deferred tax (7.86 (15.51 \ (11.93 (23.37) (8.81\ (5.49) Total Tax expense 155.08 119.37 75.98 274.45 139.12 292.03 5 Net Profit after tax (3-4) 436.74 361.99 193.75 798.73 354.83 889.85 6 Share of net profit/ (loss) from associates and joint venture, net of tax (0.551 0.08 0.74 (0.47} 1.34 0.29 7 Net Profit after taxes and share of net profiV(loss) from associales and joint 436.19 36207 194.49 798.26 356.17 890.14 venture (5+6) 8 Other comprehensive incomef(loss) (a) Items that will nol be reclassified subsequently to profit or loss: (i) Remeasurement gains/ (losses) on defined benefit plans (2.42) (2.42) (0.26) (4.84) (0.51) 3.64 (ii) Income tax relating to items that will not be reclassified to profit or loss in subsequent periods 0.61 0.61 0.07 1.22 0.13 (0.91) (iii) Share in Other comprehensive income of associates and joint venture, net of tax (0.01) - (0.01) (0.01) (0.01) 0.11 (b) Items that will be reclassified subsequently to profit or loss: Exchange differences on translating the financial statements of foreign operations t0.52J (0.40 [5.47) (0.92) (5.99 (8.74) Total other comprehensive incomef(loss), net of tax (234) (221 (5.67) (4.55) {6.38 (5.90 9 Total comprehensive income (7+8) 433.85 359.86 188.82 793.71 349.79 884.24 10 Profit for the period attributable to: i) Equity holders of the company 441.48 367.60 194.97 809.08 357.99 888.79 ii) Non-controlling interests (5.29) (5.53) (0.48) (10.82) (1.82) 1.35 11 Total comprehensive income for the period attributable to: i) Equity holders of the company 439.14 365.39 189.30 804.53 351.61 882.90 ii) Non-controlling interests (5.29) (5.53) (0.48) (10.82) (1.82) 1.34 12 Paid-up equity share capital (face value~ 2/-each) 108.06 108.05 107.96 108.06 107.96 107.97 13 Other equity 5,192.09 14 Earnings per equity share (face value~ '1/-each) -Basic(~) 8.17 6.81 3.61 14.98 6.63 16.47 -Diluted (~) 8.16 6.80 3.61 14.96 6.63 16.45 (NCii1111U111/15td) (Nfll41t11UU!Ii:>NJ (Nc>fii/UUIIIIL~J) (NQI1mnullli$c'd) (Not OMUifli:;N} (/lrll'llldll'ed) See accompanymg notes to the fmanCJal results Corporate Office Registered Office Plot No. 103, Road No.1. Jubilee Hills, Laurus Labs Limited Hyderabad, Telangana -500 033, India. Laurus Enclave, Plot Office 01. E. Bonangi Village. Parawada Mandai, Anakapalli District-531021, Andhra Pradesh, India. T +91 40 6659 4333 F +91 40 6659 4320 T +91 891 682 1101. 1102, F +91 891 682 1103 E info@lauruslabs.com. W lauruslabs.com ClN : L24239AP2005PLC047518 LAURUSLabs ( in Crores Particulars As at September 30, 2026 As at March 31, 2026 Unaudited Audited I ASSETS Non-current assets (a) Property, plant and equipment 3,846.55 3,873.23 (b) Right-of-use assets 241.30 232.71 (c) Capital work-in-progress 1,282.44 773.28 (d) Goodwill 246.30 246.30 (e) Other intangible assets 17.20 18.40 (f) Financial assets (i) Investments 310.02 309.27 (ii) Other financial assets 46.38 44.26 (g) Deferred tax assets (net) 19.74 - (h) Income tax assets (net) 4.54 244 (i) Other non<urrent assets 315.64 182.09 Total non-current assets (1) 6,330.11 5,681.98 Current assets (a) Inventories 2,659.06 2,342.16 (b) Financial assets (i) Trade receivables 2,241.53 2,155.04 (li) Cash and cash equivalents 24.45 112.66 (iii) Bank balances other than Cash and cash equivalents 4.29 1.04 (iv) Loans 0.95 0.93 (v) Other financial assets 4.63 3.21 (c) Other current assets 248.66 214.17 Total current assets (2) 5,183.57 4,829.21 Total -assets (1 +2) 11,513.68 10,511.19 II EQUITY AND LIABILITIES Equity (a) Equity share capital 108.06 107.97 (b) Other equity 5,952.51 5,192.09 Total equity attributable to equity holders of Holding Company 6,060.57 5,300.06 (c) Non<ontrolling interests 120.48 131.30 Total equity (1) 6,181.05 5,431.36 Non-current liabilities (a) Financial liabilities (i) Borrowings 553.32 611.34 (ii) Lease [Showing first 8,000 characters — download PDF for full document]